JF
AVBP icon

Jump Financial’s ArriVent BioPharma AVBP Stock Holding History

Jump Financial’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
29,644
+7,744
+35% +$229K 0.01% 1177
2026
Q1 		$505K Sell
21,900
-2,321
-10% -$52.4K 0.01% 1239
2025
Q4 		$487K Buy
24,221
+3,821
+19% +$79.5K 0.01% 1325
2025
Q3 		$376K Buy
+20,400
New +$401K ﹤0.01% 1415

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Financial's AVBP Position: Q2 2026 in Review

Jump Financial increased its ArriVent BioPharma (AVBP) stake by 35% in Q2 2026, buying an estimated $229K and bringing the position to 29,644 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #1177.

Jump Financial first reported a position in AVBP in Q3 2025 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Jump Financial held 29,644 shares of ArriVent BioPharma worth $1.03M as of Q2 2026.
  • Jump Financial bought 7,744 ArriVent BioPharma shares in Q2 2026, an estimated $229K.
  • ArriVent BioPharma made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1177 holding.
  • Jump Financial first reported a position in ArriVent BioPharma in Q3 2025 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.